
The high abundance of albumin in serum represses the signals for low abundance proteins, thereby interfering with the resolution and sensitivity of many protein profiling techniques. BSG refines the albumin depletion protocols establishing two albumin removal methods using chemical based proteome fractionation systems. The matrices AlbuSorb™ and AlbuVoid™ were tested on human, sheep, bovine, mouse, goat, rat, and calf from serum and plasma using a simple protocol. AlbuSorb™, facilities binding of albumin (>90%) thereby recovering the proteins in the flow-through. AlbuVoid™, by contrast, voids out the majority of albumin (>90%) in the flow-through and wash fractions. In the final elution step the low abundance proteins are enriched.AlbuTrial kit™ includes 1 gm of AlbuSorb™ and 5 Preps of AlbuVoid™ with respective buffers.
| Product | Size | Quantity of Serum Processed | Item No. |
|---|---|---|---|
| AlbuTrial Kit™ | 5 PrepsAlbuVoid™and 1 gram ofAlbuSorb™ | 1 gram of AlbuSorb™ processes20 preps (25 µl serum) and 5Preps of AlbuVoid™ (processes200 µl serum) | AVS-05 |